Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment

Olanzapine is the one of first line antipsychotic drug for schizophrenia and other serious mental illness. However, it is associated with troublesome metabolic side-effects, particularly body weight gain and obesity. The antagonistic affinity to histamine H(1) receptors (H(1)R) of antipsychotic drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Jiamei, Huang, Xu-Feng, Pai, Nagesh, Deng, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118967/
https://www.ncbi.nlm.nih.gov/pubmed/25084453
http://dx.doi.org/10.1371/journal.pone.0104160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118967/
https://www.ncbi.nlm.nih.gov/pubmed/25084453
http://dx.doi.org/10.1371/journal.pone.0104160

Ejemplares similares